TITAN PHARMACEUTICAL INC
TTP
TTP was delisted on the 24th of December, 2008.
1 hedge funds and large institutions have $12K invested in TITAN PHARMACEUTICAL INC in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
67% less funds holding
Funds holding: 3 → 1 (-2)
96% less capital invested
Capital invested by funds: $313K → $12K (-$301K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
-$300K |
| 2 |
DOA
D'Orazio & Associates
Falls Church,
Virginia
|
-$2K |
TTP Hedge Fund Activity: Q2 2016 in Review
1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q2 2016, worth a combined $12K — down 96% from $313K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TTP and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Gagnon Securities, exiting entirely with an estimated $300K sold.
- 1 institutional investor held TITAN PHARMACEUTICAL INC (TTP) as of Q2 2016, down from 3 in Q1 2016.
- Funds reported $12K of TITAN PHARMACEUTICAL INC stock for Q2 2016, down 96% quarter-over-quarter.
- 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q2 2016 and 2 closed out, a net change of -2 holders.
- The largest TITAN PHARMACEUTICAL INC seller in Q2 2016 was Gagnon Securities, an estimated $300K sold.
Based on aggregated 13F filings for Q2 2016.